Cargando…
Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects
Beta-thalassemia major (TM) remains to be one of the major health problems particularly in developing countries. Tunisia is a part of the Mediterranean countries mostly affected by this disease which is highly concentrated in small towns in families with low-income earners. The main objectives of th...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552730/ https://www.ncbi.nlm.nih.gov/pubmed/23350015 http://dx.doi.org/10.4084/MJHID.2013.002 |
_version_ | 1782256710032818176 |
---|---|
author | Bejaoui, Mohamed Guirat, Naouel |
author_facet | Bejaoui, Mohamed Guirat, Naouel |
author_sort | Bejaoui, Mohamed |
collection | PubMed |
description | Beta-thalassemia major (TM) remains to be one of the major health problems particularly in developing countries. Tunisia is a part of the Mediterranean countries mostly affected by this disease which is highly concentrated in small towns in families with low-income earners. The main objectives of this study are to provide a description of the demographic, clinical features and transfusion-related complications in patients with TM living in Tunisia. A standardized questionnaire was sent to clinicians throughout 33 different medical institutions caring for thalassemic patients. 391 transfusion dependant thalassemic patients with a median age of 10.7 years (range 3 months- 31 years) were included in the study. The majority originated from the north west of the country. A moderate iron overload between 1501 and 2500 ng/ml was found in 61patients, while 81 patients (26.9%) had a ferritin level more than 2500 ng/ml and greater than 5000ng/ml in 21 patients (6.9%). 51 patients died from complications related to their disease. Heart failure was the main cause of death. The incidence of cardiac, endocrine, and infectious complications will be reviewed. Preventive measures such as health education, carrier screening and premarital screening remain the best ways for lowering the incidence of these diseases, which might be reflected in financial saving, social s and health benefits. |
format | Online Article Text |
id | pubmed-3552730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Università Cattolica del Sacro Cuore |
record_format | MEDLINE/PubMed |
spelling | pubmed-35527302013-01-24 Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects Bejaoui, Mohamed Guirat, Naouel Mediterr J Hematol Infect Dis Original Articles Beta-thalassemia major (TM) remains to be one of the major health problems particularly in developing countries. Tunisia is a part of the Mediterranean countries mostly affected by this disease which is highly concentrated in small towns in families with low-income earners. The main objectives of this study are to provide a description of the demographic, clinical features and transfusion-related complications in patients with TM living in Tunisia. A standardized questionnaire was sent to clinicians throughout 33 different medical institutions caring for thalassemic patients. 391 transfusion dependant thalassemic patients with a median age of 10.7 years (range 3 months- 31 years) were included in the study. The majority originated from the north west of the country. A moderate iron overload between 1501 and 2500 ng/ml was found in 61patients, while 81 patients (26.9%) had a ferritin level more than 2500 ng/ml and greater than 5000ng/ml in 21 patients (6.9%). 51 patients died from complications related to their disease. Heart failure was the main cause of death. The incidence of cardiac, endocrine, and infectious complications will be reviewed. Preventive measures such as health education, carrier screening and premarital screening remain the best ways for lowering the incidence of these diseases, which might be reflected in financial saving, social s and health benefits. Università Cattolica del Sacro Cuore 2013-01-02 /pmc/articles/PMC3552730/ /pubmed/23350015 http://dx.doi.org/10.4084/MJHID.2013.002 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Bejaoui, Mohamed Guirat, Naouel Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects |
title | Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects |
title_full | Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects |
title_fullStr | Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects |
title_full_unstemmed | Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects |
title_short | Beta Thalassemia Major in a Developing Country: Epidemiological, Clinical and Evolutionary Aspects |
title_sort | beta thalassemia major in a developing country: epidemiological, clinical and evolutionary aspects |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552730/ https://www.ncbi.nlm.nih.gov/pubmed/23350015 http://dx.doi.org/10.4084/MJHID.2013.002 |
work_keys_str_mv | AT bejaouimohamed betathalassemiamajorinadevelopingcountryepidemiologicalclinicalandevolutionaryaspects AT guiratnaouel betathalassemiamajorinadevelopingcountryepidemiologicalclinicalandevolutionaryaspects |